Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

Completed · Phase 2 · Has a placebo group

Conditions studied: Dry Eye Syndromes

In brief

The purpose of this study is to determine whether ecabet ophthalmic solution is an effective treatment for dry eye syndrome

Key facts

Study ID

NCT00370747

Run by

Bausch & Lomb Incorporated

People needed

162

Starts

2006-09-01

Expected to finish

2007-06-01

Last updated by the study team

2013-03-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male/female at least 18 years of age
• Agree to avoid disallowed medications
• Have a diagnosis of dry eye

You may not qualify if…

• Have chronic systemic inflammation
• Have active seasonal ocular allergies

Where it is running

• Study site — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.